Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma

• Published in: Experimental oncology Vol. 42; no. 3; p. 208
• Main Authors: Çavuş, B, Akyuz, F, İliaz, R, Akyuz, U, Duranyıldız, D, Serilmez, M, Tekin, D, Evirgen, S, Karaca, Ç, Demir, K, Beşışık, F, Kaymakoğlu, S
• Format: Journal Article
• Language: English
• Published: Ukraine 01.09.2020
• Subjects: Biomarkers, Tumor; Blood Chemical Analysis; Blood Proteins; Carcinoma, Hepatocellular - blood; Carcinoma, Hepatocellular - diagnosis; Carcinoma, Hepatocellular - etiology; Carcinoma, Hepatocellular - mortality; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Galectins - blood; Humans; Interferons - blood; Interleukins - blood; Liquid Biopsy - methods; Liver Neoplasms - blood; Liver Neoplasms - diagnosis; Liver Neoplasms - etiology; Liver Neoplasms - mortality; Male; Prognosis; ROC Curve; Survival Rate

Hepatocellular carcinoma (HCC) is an increasing problem worldwide. Determining a prognosis is important for the management of HCC. We aimed to investigate the impact of interleukin (IL)-29, galectin-3, leptin, fibronectin and protease-activated receptor-1 on the prognosis and diagnosis of patients w...